
About Auropol Specialities Private Limited
Data last updated:
Auropol Specialities Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2011PTC161160.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Priyanka Bhattacharya and Mandira Bhattacharya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 67 Humayun Kabir Sarani Block – G New Alipore Near B P Poddar Hospital, Kolkata, West Bengal, India – 700053.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.16 Lakh. For the same year it recorded a net loss of ₹2.21 Lakh (net margin -53%) and EBITDA of -₹2.21 Lakh (EBITDA margin -53%). Revenue has grown at a compounded annual rate (CAGR) of 269% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website auropolindia.com.
Company details
Contact details
Auropol Specialities Private Limited's registered office is in Kolkata, West Bengal. Its website is auropolindia.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address67 Humayun Kabir Sarani Block – G New Alipore Near B P Poddar Hospital, Kolkata, West Bengal, India – 700053
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Auropol Specialities Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Auropol Specialities is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Auropol Specialities Private Limited, buy the company report.
Financials of Auropol Specialities Private Limited
FY 2024 filings availableAuropol Specialities Private Limited reported revenue of ₹4.16 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -53% | ||||
| Net Profit Margin | -53% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Auropol Specialities Private Limited, buy the company report.
Board of directors of Auropol Specialities Private Limited
Auropol Specialities has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Bhattacharya Also directs: Auropol India Private Limited | Director | 20 Jul 2023 | 3 Years 3 Months | Current |
| Mandira Bhattacharya Also directs: Auropol India Private Limited | Director | 24 Mar 2011 | 15 Years 7 Months | Current |
| Biswanath Bhattacharya | Director | 24 Mar 2011 | 15 Years 7 Months | Current |
Peer comparison
Auropol Specialities Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genical Healthcare Private Limited | ₹4.17 Lakh (FY 2019) | 443.0% | Vadodara, Gujarat, India | |||
| Auropol Specialities Private Limitedthis company | ₹4.16 Lakh (FY 2024) | -₹2.21 Lakh | -53% | Kolkata, West Bengal, India | ||
| Medikrebs Formulations Private Limited | ₹4.12 Lakh (FY 2025) | -41.0% | Dhar, Madhya Pradesh, India | |||
| Surmount Formulations Private Limited | ₹4.09 Lakh (FY 2025) | 72.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Auropol Specialities Private Limited, buy the company report.
Auditor
Auropol Specialities Private Limited is audited by RAMAVATAR & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMAVATAR & ASSOCIATES | FY 2021 | 324733E |
Shareholding
The shareholding of Auropol Specialities Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Auropol Specialities Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Auropol Specialities Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Auropol Specialities Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Auropol Specialities Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Auropol Specialities Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Priyanka Bhattacharya ceased to be Additional Director on 26 Sep 2023.
Frequently asked questions
Auropol Specialities is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 March 2011 (15+ years old) and is registered under CIN U24100WB2011PTC161160.
Auropol Specialities has 3 current directors:
- Priyanka Bhattacharya - Director
- Mandira Bhattacharya - Director
- Biswanath Bhattacharya - Director
The latest financial statements of Auropol Specialities on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Auropol Specialities is U24100WB2011PTC161160. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auropol Specialities was incorporated on 24 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Auropol Specialities by revenue are Genical Healthcare Private Limited, Medikrebs Formulations Private Limited, Surmount Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Priyanka Bhattacharya ceased to be Additional Director on 26 Sep 2023. Priyanka Bhattacharya was appointed as Director on 20 Jul 2023. Arabinda Sekhar Bhattacharya ceased to be Director on 14 Mar 2019. Auropol Specialities has 5 board changes on record in total.
Auropol Specialities can be reached through the website auropolindia.com. Its registered office is in Kolkata, West Bengal, India.
The registered office of Auropol Specialities is at 67 Humayun Kabir Sarani Block – G New Alipore Near B P Poddar Hospital, Kolkata, West Bengal, India – 700053.
Auropol Specialities operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Auropol Specialities is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.

